AstraZeneca Launches Live Click-to-Chat Feature on CRESTOR and NEXIUM Consumer Websites08:05 EDT Wednesday, April 27, 2011
WILMINGTON, Del. (Business Wire) -- AstraZeneca
(NYSE:AZN) announced today the launch of “click-to-chat” on CRESTOR.com
and PurplePill.com.
The new “click-to-chat” technology gives consumers an option to contact
a live AstraZeneca customer service representative with just a click of
a button. Click-to-chat is a live, online chat option, similar to
instant messaging, and can be accessed at the “Contact Us” page of the CRESTOR®
(rosuvastatin calcium) and NEXIUM®
(esomeprazole magnesium) websites.
“AstraZeneca understands that our consumers want flexibility, especially
when it comes to health information,” said Donna Holder, senior
director, AstraZeneca Information Center. “This new resource enables
consumers to have easier access to the information they seek through the
convenience of a real-time, online channel.”
Patients can contact the AstraZeneca
Information Center by telephone at 1-800-236-9933, Monday through
Friday from 8 a.m. to 6 p.m. ET, excluding holidays, or by submitting an
e-mail request form. In addition, CRESTOR and NEXIUM brand websites
launched “Call Me Now” in October 2010. Call Me Now offers
visitors the option to receive a personal phone call from an Information
Center representative to help answer their questions about CRESTOR
or NEXIUM
without having to go through telephone prompts, wait on the line or
listen to a recorded operator.
“AstraZeneca is one of the first pharmaceutical companies to use this
technology, making it a very forward-thinking company in the
pharmaceutical industry,” said Don Keane, vice president of marketing
and product strategy for Angel, a leading provider of customer
interaction solutions such as Interactive Voice Response (IVR) and chat
technologies. “Click-to-chat enables consumers to engage in a live-chat
session and interact directly with AstraZeneca representatives, adding
another communications channel for great customer service.”
About AstraZeneca
AstraZeneca is a global, innovation-driven biopharmaceutical business
with a primary focus on the discovery, development and commercialization
of prescription medicines for gastrointestinal, cardiovascular,
neuroscience, respiratory and inflammation, oncology and infectious
disease. AstraZeneca operates in over 100 countries and its innovative
medicines are used by millions of patients worldwide.
For more information about AstraZeneca in the U.S. or our AZ&Me™
Prescription Savings programs, please visit www.astrazeneca-us.com
or call 1-800-AZandMe (292-6363).
CRESTOR is a registered trademark of the AstraZeneca group of companies.
NEXIUM and the color purple as applied to the capsule are registered
trademarks and Purple Plus and THE PURPLE PILL are trademarks of
the AstraZeneca group of companies.
1146300 3/11
AstraZenecaMedia Inquiries:Rachelle Benson,
+1-302-885-5853

Restrictions

All rights reserved. Republication or redistribution of Thomson Reuters content, including by framing or similar means, is prohibited without the prior written consent of Thomson Reuters. Thomson Reuters is not liable for any errors or delays in Thomson Reuters content, or for any actions taken in reliance on such content. ‘Thomson Reuters’ and the Thomson Reuters logo are trademarks of Thomson Reuters and its affiliated companies.